Neural Mechanisms of Clinically Designed Improvisatory Music for Alzheimer's Disease
Neural Mechanisms of Induced Calmness After Listening to Improvisatory Music: An Investigation for Healthy Individuals and Persons With Alzheimer's Dementia
1 other identifier
interventional
30
1 country
1
Brief Summary
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applicability and generalizability. We wish to examine if CDIM decreases anxiety in 15 cognitively healthy individuals and 15 Alzheimer Disease patients with anxiety (AD-A).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable alzheimer-disease
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2022
CompletedFirst Posted
Study publicly available on registry
July 28, 2022
CompletedStudy Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedMarch 22, 2024
March 1, 2024
2 years
July 17, 2022
March 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Neuropsychiatric Inventory (NPI) [NPI-1: pre-intervention; NPI-2: post-intervention]
Change in NPI (NPI-2 minus NPI-1)
Through study completion (3 years)
Change in Beck Anxiety Inventory [BAI-1: pre-intervention; BAI-2: post-intervention]
Change in BAI (BAI-2 minus BAI-1)
Through study completion (3 years)
Secondary Outcomes (5)
Change in Systolic Blood Pressure [SBP-1: pre-intervention; SBP-2: post-intervention]
Through study completion (3 years)
Change in Heart rate [HR-1: pre-intervention; HR-2: post-intervention]
Through study completion (3 years)
Change Respiratory Rate [RR-1: pre-intervention; RR-2: post-intervention]
Through study completion (3 years)
Change in Skin conductance [SC-1: pre-intervention; SC-2: post-intervention]
Through study completion (3 years)
Change in Resting state functional connectivity MRI
Through study completion (3 years)
Study Arms (2)
Alzheimer Disease (AD)
EXPERIMENTALCognitively Healthy (CH)
EXPERIMENTALInterventions
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients.
Eligibility Criteria
You may qualify if:
- Cognitively healthy individuals
- Cognitively healthy control participants evaluated through the Northwestern Mesulam Center. BAI \> 8.
You may not qualify if:
- Individuals with mild to moderate Alzheimer's disease
- This group will similarly be recruited through the Mesulam Center. All individuals recruited by the research Core at the center are well characterized tests standardized across all NIH funded Alzheimer Centers across the nation. Individuals with mild to moderate neurocognitive disorder due to AD will have an MMSE greater than \>15 and Clinical Dementia Rating (CDR) between 0.5 and 2.. They will also have a history of neurocognitive-related agitation/anxiety, and a Beck Anxiety Index (BAI) greater than 8, suggestive of at least a mild level of anxiety.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mesulam Center for Cognitive Neurology and Alzheimer's Disease
Chicago, Illinois, 60611, United States
Related Publications (5)
Bonakdarpour B, McFadden A, Zlotkowski S, Huang D, Shaker M, Shibata B, Haben W, Brashear C, Sandoval A, Breitenbach C, Rodriguez C, Viamille J, Porter M, Galic K, Schaeve M, Thatcher D, Takarabe C. Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis. Front Neurol. 2021 Dec 13;12:749782. doi: 10.3389/fneur.2021.749782. eCollection 2021.
PMID: 34966344BACKGROUNDLyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410.
PMID: 21889116BACKGROUNDBaird A, Samson S. Music and dementia. Prog Brain Res. 2015;217:207-35. doi: 10.1016/bs.pbr.2014.11.028. Epub 2015 Jan 31.
PMID: 25725917BACKGROUNDAssal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol. 2002 Aug;15(4):445-50. doi: 10.1097/00019052-200208000-00007.
PMID: 12151841BACKGROUNDSeeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007 Feb 28;27(9):2349-56. doi: 10.1523/JNEUROSCI.5587-06.2007.
PMID: 17329432BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Borna Bonakdarpour, MD, FAAN
Northwestern Mesulam Center for Cognitive Neurology and Alzheimer Disease
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Neurology
Study Record Dates
First Submitted
July 17, 2022
First Posted
July 28, 2022
Study Start
October 15, 2023
Primary Completion
October 15, 2025
Study Completion
January 15, 2026
Last Updated
March 22, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share